Cargando…

Decreased expression of ferroportin in prostate cancer

Detalles Bibliográficos
Autores principales:	Xue, Dong, Zhou, Cui-Xing, Shi, Yun-Bo, Lu, Hao, He, Xiao-Zhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882898/ https://www.ncbi.nlm.nih.gov/pubmed/33717262 http://dx.doi.org/10.3892/ol.2021.12518

Ejemplares similares

Naotaifang extract treatment results in increased ferroportin expression in the hippocampus of rats subjected to cerebral ischemia
por: Liao, Jun, et al.
Publicado: (2016)

Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin
por: Xue, Dong, et al.
Publicado: (2016)

miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2020)

Human macrophage ferroportin biology and the basis for the ferroportin disease
por: Sabelli, Manuela, et al.
Publicado: (2017)

Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer
por: Song, He, et al.
Publicado: (2022)

Decreased ferroportin in hepatocytes promotes macrophages polarize towards an M2-like phenotype and liver fibrosis
por: Cai, Chengyuan, et al.
Publicado: (2021)

Death receptor 5 expression is inversely correlated with prostate cancer progression
por: Hernandez-Cueto, Angeles, et al.
Publicado: (2017)

Mechanism of Ca(2+) transport by ferroportin
por: Shen, Jiemin, et al.
Publicado: (2023)

SPAG9 expression is increased in human prostate cancer and promotes cell motility, invasion and angiogenesis in vitro
por: Chen, Feifei, et al.
Publicado: (2022)

Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2013)

Pediatric Ferroportin Disease
por: Galicia-Poblet, Gonzalo, et al.
Publicado: (2016)

The Role of Copper in the Regulation of Ferroportin Expression in Macrophages
por: Jończy, Aneta, et al.
Publicado: (2021)

Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress
por: Jiang, Xingkang, et al.
Publicado: (2016)

[Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression
por: Cai, Chao, et al.
Publicado: (2023)

Structural basis of ion transport and inhibition in ferroportin
por: Pan, Yaping, et al.
Publicado: (2020)

[Corrigendum] Thymoquinone inhibits epithelial‑mesenchymal transition in prostate cancer cells by negatively regulating the TGF‑β/Smad2/3 signaling pathway
por: Kou, Bo, et al.
Publicado: (2023)

SMC1A promotes growth and migration of prostate cancer in vitro and in vivo
por: Pan, Xiu-Wu, et al.
Publicado: (2021)

RNA interference-mediated depletion of TRPM8 enhances the efficacy of epirubicin chemotherapy in prostate cancer LNCaP and PC3 cells
por: Liu, Tao, et al.
Publicado: (2022)

Isolation and thermal stabilization of mouse ferroportin
por: Deshpande, Chandrika N., et al.
Publicado: (2020)

A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells
por: Schcolnik-Cabrera, Alejandro, et al.
Publicado: (2020)

Ferroportin and Erythroid Cells: An Update
por: Cianetti, Luciano, et al.
Publicado: (2010)

Loss of E-cadherin promotes prostate cancer metastasis via upregulation of metastasis-associated gene 1 expression
por: Fan, Liangsheng, et al.
Publicado: (2020)

Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for Tauopathies
Publicado: (2014)

Corrigendum to “Clinical Significance of the Decreased Expression of hsa_circ_001242 in Oral Squamous Cell Carcinoma”
por: Sun, Shuai, et al.
Publicado: (2019)

Corrigendum to “PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling”
por: Xue, JunLi, et al.
Publicado: (2020)

Correction to ‘BAP18 coactivates androgen receptor action and promotes prostate cancer progression’
por: Sun, Shiying, et al.
Publicado: (2021)

[Corrigendum] NEP1‑40 promotes myelin regeneration via upregulation of GAP‑43 and MAP‑2 expression after focal cerebral ischemia in rats
por: Zhao, Hong, et al.
Publicado: (2023)

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]
Publicado: (2014)

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)

Retraction Note: Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2015)

Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer
por: Lin, Junhao, et al.
Publicado: (2022)

Naotaifang extract treatment results in increased ferroportin expression in the hippocampus of rats subjected to cerebral ischemia
por: LIAO, JUN, et al.
Publicado: (2015)

Structural basis of ferroportin inhibition by minihepcidin PR73
por: Wilbon, Azaan Saalim, et al.
Publicado: (2023)

The functional significance of microRNA-145 in prostate cancer
por: Zaman, M S, et al.
Publicado: (2011)

Relationship between gene expression and the accumulation of catechin during spring and autumn in tea plants (Camellia sinensis L.)
por: Liu, Min, et al.
Publicado: (2015)

A disease-causing mutation K240E disrupts ferroportin trafficking by SUMO (ferroportin SUMOylation)
por: Bayele, Henry K., et al.
Publicado: (2021)

[Corrigendum] DNA methylation is involved in the aberrant expression of miR‑133b in colorectal cancer cells
por: Lv, Lv, et al.
Publicado: (2023)

Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”
por: Masson, Susan, et al.
Publicado: (2016)

Inhibitory activity of apogossypol in human prostate cancer in vitro and in vivo
por: Zhan, Wenhua, et al.
Publicado: (2018)

RLIP76 decreases apoptosis through Akt/mTOR signaling pathway in gastric cancer
por: Wang, Wenwen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j1i9263b9h8kiahss6hr4e0t27